cancer-drug - Latest News on cancer-drug | Read Breaking News on Zee News

Sun Pharma recalls 200 vials of cancer drug: FDA

Last Updated: Thursday, July 03, 2014, 13:22

Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.

Glenmark faces patent infringement suit for cancer drug in US

Last Updated: Tuesday, December 31, 2013, 14:33

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.

Sun Pharma stock up nearly 3%; scales 52-week high in intra-day

Last Updated: Thursday, September 26, 2013, 11:37

Shares of Sun Pharma Thursday closed with nearly 3 percent gains on hopes of higher sales of a key cancer drug in the US, amid reports that the drug would likely to be in shortage soon.

Roche not to pursue patent for breast cancer drug in India

Last Updated: Friday, August 16, 2013, 18:04

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

Last Updated: Monday, August 05, 2013, 22:29

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.

India partly revokes Roche cancer drug patent

Last Updated: Sunday, August 04, 2013, 18:39

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.

Dr Reddys launch generic cancer drug in US market

Last Updated: Friday, July 12, 2013, 14:46

The company's product is generic version of Dacogen, manufactured and sold by Eisai Inc under license from Astex Pharmaceuticals Inc, it added.

SC order on Novartis will impact investment in India: USIBC

Last Updated: Wednesday, April 03, 2013, 08:50

Over 40 countries including China, Russia and Taiwan have already granted a patent for Novartis' Glivec and India now stands out as unique for not granting a patent to this incremental innovation, the statement said.

MNC lobby upset over Novartis patent verdict

Last Updated: Tuesday, April 02, 2013, 16:04

The SC judgment caps about seven year of tussle launched by Novartis seeking patent cover for its cancer medicine Glivec.

Will not invest on R&D in India, says Novartis

Last Updated: Monday, April 01, 2013, 18:19

Swiss pharma major Novartis Monday said it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent plea on cancer drug Glivec.

SC decision on Novartis to benefit poor patients: Pharma cos

Last Updated: Monday, April 01, 2013, 15:09

Novartis, however, said: "This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options".

Novartis recovers early losses; stock ends nearly 2% down

Last Updated: Monday, April 01, 2013, 13:02

After falling about 7 percent and hitting one-year low of Rs 558.10 during the day, shares of the drug firm finally ended at Rs 587.95, down 1.81 percent on the BSE.